Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parameswaran Hari

Showing results (1-10 of 255) with videos related to

Pageof 26
Sort By:
Hematology/Oncology and Stem Cell Therapy|June 21, 2017
Recent advances in understanding multiple myelomaParameswaran Hari
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 9, 2016
Resistant or Sensitive: Time Is of the Essence: Response to Malek et alParameswaran Hari
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 23, 2017
Chemo-Mobilization in Myeloma-Diminishing Returns in the Era of Novel Agent Induction?Parameswaran Hari
Transplantation and Cellular Therapy|February 23, 2022
A Review of Propylene Glycol-free Melphalan Conditioning for Hematopoietic Cell Transplantation for Multiple Myeloma and Light Chain AmyloidosisParameswaran Hari, Saurabh Chhabra
Blood|September 10, 2008
Nonmyeloablative conditioning for relapsed follicular lymphomaKoen van Besien, Parameswaran Hari
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|May 26, 2010
Light chain amyloidosis circa 2010: six prognostic markers and one sobering realityRaymond Q Migrino, Parameswaran Hari
International Journal of Hematologic Oncology|October 11, 2018
Propylene glycol-free melphalan as conditioning regimen for autologous transplantation in myelomaOmar S Aljitawi, Parameswaran Hari
BMJ Neurology Open|March 8, 2021
Plegia to walking: AHSCBMT in severe NMOSD relapseNicola Carlisle, Parameswaran Hari, Staley Brod
JAMA Oncology|August 12, 2018
Meta-analysis to Evaluate High-Dose Therapy Followed by Stem Cell Transplant in Patients With Multiple Myeloma-ReplyBinod Dhakal, Aniko Szabo, Parameswaran Hari
Blood|June 16, 2012
Allogeneic hematopoietic cell transplantation for myelofibrosis in the era of JAK inhibitorsVikas Gupta, Parameswaran Hari, Ronald Hoffman
Pageof 26

Showing results (1-10 of 255) with videos related to

Sort By:
Pageof 26
Hematology/Oncology and Stem Cell Therapy|June 21, 2017
Recent advances in understanding multiple myelomaParameswaran Hari
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 9, 2016
Resistant or Sensitive: Time Is of the Essence: Response to Malek et alParameswaran Hari
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 23, 2017
Chemo-Mobilization in Myeloma-Diminishing Returns in the Era of Novel Agent Induction?Parameswaran Hari
Transplantation and Cellular Therapy|February 23, 2022
A Review of Propylene Glycol-free Melphalan Conditioning for Hematopoietic Cell Transplantation for Multiple Myeloma and Light Chain AmyloidosisParameswaran Hari, Saurabh Chhabra
Blood|September 10, 2008
Nonmyeloablative conditioning for relapsed follicular lymphomaKoen van Besien, Parameswaran Hari
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|May 26, 2010
Light chain amyloidosis circa 2010: six prognostic markers and one sobering realityRaymond Q Migrino, Parameswaran Hari
International Journal of Hematologic Oncology|October 11, 2018
Propylene glycol-free melphalan as conditioning regimen for autologous transplantation in myelomaOmar S Aljitawi, Parameswaran Hari
BMJ Neurology Open|March 8, 2021
Plegia to walking: AHSCBMT in severe NMOSD relapseNicola Carlisle, Parameswaran Hari, Staley Brod
JAMA Oncology|August 12, 2018
Meta-analysis to Evaluate High-Dose Therapy Followed by Stem Cell Transplant in Patients With Multiple Myeloma-ReplyBinod Dhakal, Aniko Szabo, Parameswaran Hari
Blood|June 16, 2012
Allogeneic hematopoietic cell transplantation for myelofibrosis in the era of JAK inhibitorsVikas Gupta, Parameswaran Hari, Ronald Hoffman
Pageof 26